Unknown

Dataset Information

0

N-Acetylaspartate Drives Oligodendroglial Differentiation via Histone Deacetylase Activation.


ABSTRACT: An unmet clinical goal in demyelinating pathologies is to restore the myelin sheath prior to neural degeneration. N-acetylaspartate (NAA) is an acetylated derivative form of aspartate, abundant in the healthy brain but severely reduced during traumatic brain injury and in patients with neurodegenerative pathologies. How extracellular NAA variations impact the remyelination process and, thereby, the ability of oligodendrocytes to remyelinate axons remains unexplored. Here, we evaluated the remyelination properties of the oligodendroglial (OL) mouse cell line Oli-neuM under different concentrations of NAA using a combination of biochemical, qPCR, immunofluorescence assays, and in vitro engagement tests, at NAA doses compatible with those observed in healthy brains and during brain injury. We observed that oligodendroglia cells respond to decreasing levels of NAA by stimulating differentiation and promoting gene expression of myelin proteins in a temporally regulated manner. Low doses of NAA potently stimulate Oli-neuM to engage with synthetic axons. Furthermore, we show a concentration-dependent expression of specific histone deacetylases essential for MBP gene expression under NAA or Clobetasol treatment. These data are consistent with the idea that oligodendrocytes respond to lowering the NAA concentration by activating the remyelination process via deacetylase activation.

SUBMITTER: Dominicis A 

PROVIDER: S-EPMC10378218 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

N-Acetylaspartate Drives Oligodendroglial Differentiation via Histone Deacetylase Activation.

Dominicis Alessandra A   Del Giovane Alice A   Torreggiani Matteo M   Recchia Antonella Damiana AD   Ciccarone Fabio F   Ciriolo Maria Rosa MR   Ragnini-Wilson Antonella A  

Cells 20230714 14


An unmet clinical goal in demyelinating pathologies is to restore the myelin sheath prior to neural degeneration. N-acetylaspartate (NAA) is an acetylated derivative form of aspartate, abundant in the healthy brain but severely reduced during traumatic brain injury and in patients with neurodegenerative pathologies. How extracellular NAA variations impact the remyelination process and, thereby, the ability of oligodendrocytes to remyelinate axons remains unexplored. Here, we evaluated the remyel  ...[more]

Similar Datasets

| S-EPMC10050190 | biostudies-literature
| S-EPMC8156399 | biostudies-literature
| S-EPMC2925045 | biostudies-literature
| S-EPMC2922493 | biostudies-literature
| S-EPMC4728416 | biostudies-literature
| S-EPMC3328162 | biostudies-other
| S-EPMC10901458 | biostudies-literature
| S-EPMC8457175 | biostudies-literature
| S-EPMC3119038 | biostudies-literature
| S-EPMC8887482 | biostudies-literature